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Abstract 
 
 
Diseases caused by multidrug resistant Gram-negative bacterial strains such as 
Enterobacteriaceae members (Salmonella, Pseudomonas & Klebsiella) claim millions of lives 
every year. One of the major virulence determinants of these bacteria are the polymeric surface 
antigens like capsular polysaccharides (CPS), exopolysaccharides (EPS) & lipopolysaccharides 
(LPS). A detailed understanding of these surface antigens is essential to develop drugs against 
bacterial infections. However, this is made difficult by the large variety of surface antigens that 
have been discovered to date. To this end, an organized repository of all available structures, 
functions and biochemical information about the various Gram-negative surface antigens is 
highly essential. Although several efforts have been made previously to develop databases of 
bacterial surface antigens, they offer only limited information. In the present study, we focus on 
the development of a database for Group capsular polysaccharides (K antigens) of E. coli. It is 
noteworthy that E. coli is used as a model system here, as it is very well studied and its capsular 
polysaccharides have been well characterized. The database, named EK3D (E. coli K antigen 3D 
Structural Database) provides information about the structure of Group capsular antigens and the 
proteins involved in its biosynthesis. The database will also enable generation of polymeric CPS 
structures of varying lengths for modeling and Molecular dynamics (MD) studies. Thus, EK3D 
will provide comprehensive information about group K antigens of E. coli and be a valuable 
resource for researchers. 
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CHAPTER 1 
      INTRODUCTION 
1.1 BACTERIA AND ASSOCIATED DISEASES 
Microorganisms play an important role in causing a wide range of diseases. Bacteria are one 
among these that exhibit higher rate of antimicrobial resistance, and are known to contain 
structure like cell envelope that helps in protection and adaptation of the organism. The cell 
envelope of Gram positive organisms has thick layer of peptidoglycan. Teichoic acids, a type 
of polyalcohols are present and are linked to lipids to form lipoteichoic acids within the 
cytoplasmic membrane. In Gram negative cell envelope peptidoglycan layer is thin, teichoic 
acids are absent and there is an outer membrane in addition to peptidoglycan layer which is 
made up of phospholipids and lipopolysaccharides. The porins present in the impermeable 
phospholipid membrane allow passive transport of many ions, sugars  and aminoacids across 
the outer membrane. Periplasm, present between inner and outer membrane, contains 
peptidoglycan layer and is involved in transport of proteins. Both Gram positive and Gram 
negative organisms are known to be responsible for causing wide range of diseases. 
Gram positive organisms and their associated diseases include Staphylococcus and 
Streptococcal infections. Gram negative organisms like E. coli, Klebsiella, Neisseria and 
Haemophilus are known to be associated with diarrhoea, neonatal meningitides, urinary tract 
infections, septicemia etc. Gram negative and Gram positive bacteria and their associated 
diseases, no of capsular serotypes and their antigenic determinant are shown in Table 1. 
Though the diseases caused by these bacteria can be treated with antibiotics, the overuse of 
these antibiotics is one of the reasons for the development of resistance. 
1.2 Multi Drug Resistance 
Emergence of multi drug resistance (MDR) has become a ‘major global threat’, claiming 
millions of lives every year. Currently the estimate is 10 million deaths each year (Reardon, 
2014). The steadily rising MDR strains of bacteria (Reardon, 2014),  as indicated in Figure 1, 
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has essentially brought us to a “post antibiotic era”, as described by WHO (World Health 
Organization). Hence, bacterial strains that have evolved multi drug resistance, such as 
Mycobacterium, Klebsiella, Gonorrhoea etc are major threat to public health. The present 
data where in, the action of major drug like Carbapenem is the last resort drug to treat disease 
Table 1. Clinically important bacteria  & associated diseases (Nwodo et al., 2012) 
Bacterial 
Species 
Pathogenic 
serotype 
Capsular 
Antigen 
Associated clinical Disease 
 E. coli  >80 K antigen Diarrhoea,  neonatal meningitis and urinary tract 
infection  
N. meningitidis  >10 K antigen Meningitis, meningococcemia  
K. pneumonia  >80 K antigen Pneumonia,  bacteremia,  urinary tract infection 
(UTI)  
St. pneumoniae  >96 CPS Otitis media, bronchopneumonia and meningitis  
S. aureus  >11 CPS Staphylococcal scalded skin syndrome, septic 
arthritis, staphylococcal endocarditis and atopic 
dermatitis  
 
pneumonia no longer works. Bacteria mutate rapidly and are capable of easily evading the power 
of antibiotics. The term ESKAPE was given to collectively summarize organisms Enterococcus, 
Staphylococcus, Klebsiella, Acinetobacter, Pseudomonas, and ESBL (Enterobacter and 
Esherichia coli) that deveoped multidrug resistance.  
O’Neill putforth the term BRIC (Brazil, Russia, India and China) and more recently MINT 
(Mexico,Indonesia, Nigeria and Turkey) states where the impact of multi drug resistance varies 
(Reardon, 2014). Gram negative bacteria are at the growing level of drug resistant infections. 
Deaths attributed to AMR (antimicrobial resistance) every year by 2050 will be more than one in 
four deaths affecting great number of population. Current research suggests that switching 
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between two antibiotics in a well designed sequence may prove it to be a new way to fight the 
antimicrobial resistance for which clinical trials are on the way (Westly, 2012). 
 
 
Figure 1. Global map illustrating the world wide spread of antibiotic 
resistance (Reardon, 2014). The antibiotic-resistant bacteria and drug pairs 
monitored were fewer than 5 in large number of areas and are shown in dark green 
colour. No data is available in some areas as shown in orange.  
 
Recent WHO report on global surveillance shows (Figure 2 & 3) increased resistance rate 
towards broad spectrum antibiotics. Antibacterial resistance in E. coli against third generation 
cephalosporins & carbapenems is due to the release of beta-lactamases which destroy beta-
lactam antibacterial drugs.  
 
WHO South East Asia region report 
Information and data available for selected diseases and organisms reveal that AMR is a 
burgeoning and often neglected problem. Since 2011 the awareness has been increasing to 
combat AMR. 
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Resistance to  cephalosporins and fluoroquinolones in Escherichia coli 
Data obtained from various states has been summarized by WHO and the (Figure 3) shows the 
information collected from different regions summarizing the resistance rate to be higher for 
fluoroquinolones. Some bacterial strains emerge as antibiotic resistant strains upon acquiring 
drug resistance conferring pathogenicity to the organism. Numerous studies on bacteria have 
focused on the cell surface glycoconjugates of microorganisms, because of their importance in 
pathogenicity. 
 
Figure 2. Global map on cephalosporin resistance (Review on Antimicrobial resistance, 
Global surveillance, 2014). 
 
Table 2. Data obtained from Member States as summarized by WHO on E. coli MDR 
(Review on Antimicrobial resistance, Global surveillance, 2014). 
Drug Data sources based on at least 
30 tested isolates 
Overall reported range of 
resistant proportion (%) 
Fluoroquinolones South-East Asia Region 
– National data (n=5 countries) 
– Publications (n=19) from 2 
additional countries 
32–64 
4–89 
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Cephalosporins South-East Asia Region 
– National data (n=5 countries) 
–Publications (n=26) from 2 
additional countries 
16–68 
19–95 
 
 
Figure 3. Global map on fluoroquinolone resistance (Review on Antimicrobial resistance, 
Global surveillance, 2014). 
1.3 BACTERIAL POLYSACCHARIDES 
Gram-negative bacteria are known to contain polysaccharides as the abundant polymer and there 
is a remarkable variation in the polysaccharides produced by various strains. 
1.3.1 Diversity of bacterial polysaccharides 
Polysaccharides are one of the virulent factors in Gram negative bacteria. The major 
polysaccharides known are lipopolysaccharides and capsular polysaccharides. Different O 
antigens and K antigens are reported in various serotypes of E. coli. Nearly 167 O serogroups 
and 80 K serogroups are noted.  Another exopolysaccharide that is loosely associated with cell 
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present in many E. coli strains is colonic acid. Although this doesn’t play a role in bacterial 
pathogenecity, it helps bacterium to survive outside the host.  
The antigen serotyping is useful in understanding the pathogenesis and in epidemiological 
studies in tracing the origin of disease. Each antigenic structure composition is different for a 
particular serotype which helps in identification of specific strains. Based on the antigens 
associated with the outer membrane like LPS (O antigen), CPS (K antigen) and flagellar (H 
antigen), in 1940’s Kauffman proposed earliest classification based on O, K and H antigens. 
Wherein, O antigen consists of polysaccharide attached to a lipid A-core unit of outer membrane 
(part of LPS). H antigen is flagellar subunit associated antigen which is also a determinant of 
virulence. K antigen is the high molecular weight capsular polysaccharide associated with outer 
membrane of  the bacteria (Figure 4). There exists a greater structural diversity in 
polysaccharides between different bacterial species and also within the same bacterial species 
which can be exploited to engineer novel polysaccharides molecules with particular biochemical 
or immunological properties. Significant advances has been made in understanding the 
biosynthesis and surface assembly of these structures (Refer complex carbohydrate structure 
database-www.ccrc.uga.edu/) (Whitfield, 1988). 
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Figure 4. Schematic representation of bacterial LPS and CPS showing 
surface associated Gram negative polysaccharides. The K antigen is 
shown attached to the lectin wzi and O antigen is shown attached to core 
and lipid A of LPS and KLPS is K antigen attached to LPS. 
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1.3.2 Capsular antigen/ K antigen 
Capsule is mainly, a polysaccharide layer  present in both  Gram positive and Gram negative 
organisms. Figure 5 depicts the  electron micrograph of E. coli capsule showing the morphology 
of CPS on surface. Capsular polysaccharide (CPS) is tightly associated with cell surface non-
covalently and protects bacteria from host immune system. CPS serves as an important model 
system for studies on other bacteria. 
Functions of capsules include prevention of dessication, adherence, resistance to specific (mimic 
host cellular proteins) & non-specific host immunity (complement-mediated 
opsonophagocytosis).  
 
Figure 5. Electron micrograph illustrating the CPS on 
bacterial surface of E. coli B44 (O9:K30). Adopted from 
(Rahn et al., 2003).   
 
1.4  E. coli CAPSULAR GROUP CLASSIFICATION 
Considering the present E. coli model system, classification of E. coli into groups is based on K 
antigen, its biosynthesis mechanism, genetics & biochemical characters. Based on capsular 
antigen surface expression  & assembly mechanism, there are only two pathways used in E. coli  
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i.e, Wzy-dependent pathway and ABC transporter pathway. E. coli group 1 and 4 capsules share 
a common assembly system, and this is different from the one used for group 2 and 3 capsules.  
Table 3. E. coli capsular group classification  showing different characteristics (Whitfield, 
2006) 
 
Characteristics Group-1 Group-2 Group-3 Group-4 
Type of 
polysaccharide 
Acidic 
polysaccharides 
(Uronic acids) 
Repeat units vary 
extensively 
Repeat units vary Acidamido 
sugars 
Occurrence Found in isolates 
that cause 
intestinal 
infections 
Found in isolates 
that cause 
extraintestinal 
infections 
Found in isolates 
that cause 
extraintestinal 
infections 
Found in 
isolates that 
cause intestinal 
Infections 
Co-expression 
with colonic 
acid 
 
Absent 
 
Present 
 
Present 
 
Present 
 
Terminal lipid 
moiety 
KLPS-Lipid A 
KAg-unknown 
α-
glycerophosphate 
α-
glycerophosphate? 
KLPS-Lipid A 
KAg-unknown 
Polymerization 
type 
Wzy dependent ABC transporter 
dependent 
ABC transporter 
dependent 
Wzy dependent 
Serotypes K27,K29,K30 K1,K2a,K4,K5 K10,K54 K40 
Capsular 
similarity 
Klebsiella, 
Erwinia 
Neisseria, 
Haemophilus 
Neisseria, 
Haemophilus 
None 
Group 1 & 4 and group 2 & 3 have similarities with respect to genetic locus, thermostability, 
mechanism of biosynthesis (Table 3). Group-1 capsules are high molecular weight 
polysaccharides with low electrophoretic mobility and contain hexouronic acids as the acidic 
component. They are coexpressed with essentially O8 and O9 antigens at all growth 
temperatures, and are heat stable. Group-II capsules on the other hand are known to contain 
acidic components like KDO, NeuNAc or phosphate as unusal residues. They show greater 
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electrophoretic mobility and resemble Neisseria meningitides or  Haemophilus influenzae. These 
capsules are heat labile at P
H
 5-6 and are coexpressed with many O antigens. 
Table 4.  List of K antigens belonging to different E. coli group capsules. 
Group-1- K26, K27, K28, K29, K30 ,K31, K32, K33, K34, K35, K36, K37, K39, K42, K55,                   
                 K102, K103  
Group-2- K1, K2a, K2ab, K3, K4, K5, K6 , K7, K11, K12, K13, K14, K15, K16, K18,       
               K19, K20, K22, K23, K24, K51, K52, K53, K54, K74, K92, K93, K95, K97, K100 
Group-3- K3, K10, K11, K54, K96, K98 
Group-4- K8, K9, K38, K40, K44, K45, K46, K47, K48, K49, K50, K57, K83, K85,                        
K87, O111, K101  
(Max. Sussman, 1997, Escherischia coli : Mechanisms of Virulence, Pg-113-122, 
books.google.co.in/ ,Orskov et al, Methods in microbiology,Vol-14). 
Depending on the sugar composition, linkage specificity, as well as substitution with non 
carbohydrate residues about 80 K antigen serotypes are known in E. coli. The structures of many 
of these antigens is already determined. However, no 3D structures are available.  
1.4.1  Biosynthesis & Surface assembly of Group-1 to Group-4 capsules 
1.4.1.1 Group-1 capsules biosynthesis and surface assembly 
Bacteria use limited biosynthesis mechanisms despite diversity in capsular phenotypes. The 
biosynthetic pathway and the proteins involved in biosynthesis reflect the unique repeat unit 
structure of each K antigen. Group 1 K antigens are expressed as CPS and KLPS. In case of CPS, 
the repeat unit polymerizes to form a heavy molecular weight structure that non-covalently 
associates with cell surface whereas KLPS consists of K antigen repeating unit linked to lipid A 
core of LPS. Gram-negative bacterial outer membrane has been represented in Figure 4.  
Capsular assembly via Wzy-dependent pathway begins in the cytoplasm with the synthesis of 
lipid-linked polysaccharide repeat units. Initially first sugar is added by the initiating glycosyl 
transferase (WbaP) to the polyisoprenoid lipid carrier molecule undecaprenyl phosphate (UndP) 
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Figure 6. Schematic representation of Gram-negative bacterium capsular biosynthesis & its 
surface expression. Left view- Wzy dependent Polymerization pathway of group-1 and right 
view  ABC transporter pathway of group-2 capsules. LPS consists of O-antigen (Black) repeating 
unit covalently linked to lipid A (Orange), Core(Yellow). KLPS consists of few K antigen repeat 
units (white) linked to lipid A core. K antigen (repeat unit with variable colours red, blue, green) 
non covalently attached to lectin protein Wzi. 
 
in the form of an activated nucleotide precursor at the inner leaflet of the inner membrane (IM), 
(Undecaprenol also serves as a scaffold for organizing proteins including GTs (Glycosyl 
transferases), and the lipid: protein complexes may alter the biophysical properties of the local 
membrane environment, perhaps aiding the flipping activity) resulting in a pyrophosphate 
linkage with the carrier (undecaprenyl pyrophosphate, UndPP). Subsequent sugar addition occurs 
by specific glycosyltransferases which result in the synthesis of an individual UndPP linked 
polysaccharide repeat unit (referred to as an ‘O unit), after which a series of inner membrane 
assembly proteins take over (Table 5). The UndPP-linked repeat units are translocated from the 
inner to the outer membrane by the Wzx flippase. Polymerization by Wzy via catch-and-release 
mechanism occurs. In case of K-Antigen synthesis sugar-unit addition occurs at the reducing 
terminus of the growing chain, the length of which is regulated by the polysaccharide co-
polymerase. Continuation of polymerization requires Wzc phosphorylation (C-terminal tyrosine 
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residues) and successive dephosphorylation of Wzb (Protein tyrosine phosphatase) continues the 
polymerization cycle. Wzc is also involved in closing and opening of Wza. The polymerized 
glycan is then anchored onto the bacterial surface by Wzi that is located on the outer membrane. 
In KLPS the K-antigen is found attached to the mature LPS molecule (Whitfield, 2006).  
  
Table  5. Proteins involved in biosynthesis of group-1 capsular 
polysaccharides in E. coli. 
 
 
1.5 DATABASES 
Great number of databases  have been providing information about carbohydrates which are 
often, referred to as glycans (Campbell et al., 2014). Although in the past, number of databases 
have been developed with respect to carbohydrate structures like, CSDB (Carbohydrate structure 
database), PolysacDB (Database of antigenic polysaccharides of microbes) (Aithal et al., 2012), 
ECODAB (E. coli O antigen database) (Rojas-Macias et al., 2015) etc, the information provided 
lacks the 3D structural data. ECODAB database provides information on O antigen structures, 
NMR chemical shifts, few cross reactivity relationships of a particular serogroups. Some 
databases give sequence based information like Glycan fragment database (GFDB) (Jo and Im, 
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2013), primary structure information, or glycoprotein structural information (GlycosuiteDB) 
(Cooper et al., 2003, Cooper et al., 2001). E. coli K antigens exhibit conformational complexity. 
EK3D was developed in order to provide the necessary information about the K antigen 
structures among different E. coli groups which enables the better understanding of host-
pathogen interaction (Sarkar and Perez, 2012). EK3D may serve as an example to develop other 
antigen determinant based databases that are limited.   The main features of EK3D are it offers  
different K antigen structures of E. coli group capsules, serves as a tool to generate polymeric 
structures of K-antigen repeat units, provides related database  links for cross reference and its 
implementation as webserver through HTML coding provides data access for the research 
purpose. 
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SCOPE OF THE PRESENT STUDY 
With the increased incidence of multi-drug resistant Gram-negative bacterial infections and the 
lack of effective treatment options, the focus of current research has shifted to the discovery of 
new antibacterial drug targets. This in turn requires an in-depth understanding of the bacterial 
surface antigen structure and underlying virulence mechanisms. In this study, we focus on one 
of the major Gram-negative virulence determinants, the Capsular polysaccharide. Though the 
CPS has been well characterized in a number of Gram-negative bacteria, a central repository of 
all available information is lacking. For instance, the ECODAB database 
(http://www.casper.organ.su.se/ECODAB) focuses on O-antigen structures of E. coli , EcoCyc 
(http://ecocyc.org) is restricted to only E. coli K12 strain. Likewise, BPGD gives information 
about bacterial polysaccharide genes but is restricted to nomenclature only (Rojas-Macias et al., 
2015). Thus, a comprehensive K antigen database if present would be a valuable resource for 
researchers. In the present study, we develop EK3D (E. coli K antigen 3dimensional Structural 
Database), which provides information about Group-1 to 4 K antigen structures of E. coli. 
Structural information about the proteins involved in the assembly of the Group capsules is also 
available. We also aim to develop a modeling tool to generate Capsular polysaccharides of 
specified length from the known repeating unit structures. This database will thus be a valuable 
research tool that will help accelerate research in the field of capsular polysaccharides like host-
pathogen interaction, docking studies and K antigen structure determination. 
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CHAPTER 2 
METHODS 
Bacteria produce larger amounts of glycans as part of capsular polysaccharide, 
lipopolysaccharide, EPS and antibiotic glycosides. There is a greater need to understand the 
structure, recognition, metabolism and biosynthesis of glycans and glycoconjugates. In most of 
the pathogens, CPS are the well known virulent factors (Merritt et al., 2013). As E. coli cells 
serve as model organism to study glycosylation and glycoprotein expression developing a 
database with a systamatic record of related information may serve as a major tool in making 
therapeutics and vaccines. An organized database is easy to  track and verify and thus, database 
of E. coli K-antigens can store related information on different subjects. In this context, we aim 
to create a 3D database of E. coli K antigen structures, named EK3D (E. coli K antigen 3D 
Structural Database). A basic overview of database development is provided below, followed by 
a detailed description of EK3D. 
2.1 DATABASE DEVELOPMENT 
Database management systems are the computer based software applications that interact with 
the user to analyze and capture data. The data is initially entered and stored for the retrieval 
process. On basic linux ubuntu server the following drives were mounted (MYSQL, APACHE2, 
PHP) (server sided). 
2.1.1  Mounting drives  
The following drives were installed to establish a database. 
Step by step process to install programmes like Apache2, Mysql, PHP, Kozomer was carried out. 
Popular setups for ubuntu server are designated as LAMP installations 
(Linux+Apache2+mysql+Php). 
2.1.1.1 Apache2: It is a HTTP web server application in the internet world (World wide web) 
and is found to be secure and comprehensive in terms of features it provides. It allows virtual 
hosting i.e, Apache installation serves simultaneously, many different websites (Figure 7 & 8). 
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2.1.1.2 MYSQL: (Structure query language) It is a database management system which is 
relational database that stores data in tables for easy access and data retrieval. Its found to be an 
open source whose software can be used or modified by ayone. It is very fast, reliable and works 
in server/client systems. 
2.1.1.3 PHP: (Hyper text pre processor) It is a server sided scripting language. This is essential 
for web development as the code is executed on the server, generating html that is sent to the 
clients later. All the html files can be processed with PHP. It is simple and has advanced features. 
This is used for web designing of database driven websites.  
HTML Files: (Hyper Text Markup Language) which is a computer language that directs the 
formatting of text pages which will be displayed as webpages. This helps to use fonts, colors, 
create headlines, and graphics. It is a predominant language of world wide web. It is a coding 
language used to create our own website. 
 
Figure 7.  Steps involved in implementation of webserver. 
 
 
Figure  8. Client-server working protocol. 
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2.2 DEVELOPMENT OF EK3D, AN E. COLI K ANTIGEN 3D STRUCTURAL 
DATABASE 
   2.2.1 Collection of data  
The capsular antigen (K antigen) of E. coli has been extensively studied with >80 antigen 
structures known so far (Orskov et al., 1977). From a preliminary literature survey, we found that 
though the carbohydrate composition and connectivity of these sugars had been determined, 
there was a marked lack of structural information. As a first step towards the development of E. 
coli K antigen, these antigen structures were collected from scientific literature and other web 
resources. A list of the K antigens and the corresponding references is shown in Table 4. 
 
2.2.2 Generation of E. coli K antigen repeating units & their energy minimization 
The E. coli K antigen repeating units were generated using GLYCAM,  SWEETDB and manual 
pymol builder. The PyMOL Molecular Graphics System, Version 1.7.4 Schrödinger, LLC, (Loss 
et al., 2002). 
  2.2.3 CHARMM force field 
CHARMM (Chemistry at HARvard Macromolecular Mechanics) is a program widely used for 
macromolecular mechanics and dynamics with potential energy functions for carbohydrates, 
proteins, nucleic acids, and lipids. The molecular system potential energy at a time t1 can be 
expressed as a function of atomic positions using the familiar energy terms in Equation   
………………(1) 
V(r1, . . . ,rN) - ∑i<jVbonds(ri j) + ∑i<j<k Vangles(θi jk) + ∑i<j<k<h Vdihedral(φi jkh) + 
          ∑i<jVcoul.( rij)  +∑i<jVLJ ( rij)……………….(1) 
Vbonds(rij) - ½ k
b
 i j(rij _ r
0
 ij)
2  ………………(2) 
Vangles(θijk) - ½k
θ
ijk(θijk-θ
0
ijk)
2  ………………(3) 
Vdihedral(φijkl) - ½kφ(1+ cos(nφ+γ))  ……………..(4) 
k
b
 i j  and r
0
 i j indicate the bond-stretching constant and the equilibrium distance from eq-2 
k
θ
ijk and θ
0
ijk indicate the angle-bending constant and the equilibriumangle from eq-3 
31 
 
kφ , nφ and γ are the torsion constant, multiplicity and phase angle, respectively.  
Where as Vbonds, Vangles, Vdihedrals refer to the potential energy with respect to bond 
stretching, angle bending, and dihedral angle rotations. VCoul and VLJ refer to the pairwise 
electrostatic interaction and to the Lennard-Jones (LJ) repulsion–dispersion potential terms, 
respectively. Classical force fields are defined by the functional form of these components and 
by the set of parameters that each term requires. 
2.2.3.1 Parameterization of unusual sugars 
Protein and nucleic acids are made from linear assembly of residues whereas because of the 
conformational flexibility of glycans, development of carbohydrate forcefield is challenging. 
Computational methods based on empirical force fields can contribute to the better 
understanding of structure and dynamics of carbohydrates. The presence of chiral centres in 
monosaccharides and branched nature of glycans makes the parameterization and the validation a 
difficult task. Considering two hexopyranose monosaccharides nearly 20 distict dissacharides 
can be formed where as only one dipeptide can be generated from the two aminoacids. 
CHARMM additive all atom empericial force field for pyranoses and furanoses is built based on 
existing CHARMM parameters (Hatcher et al., 2009).  
CHARMM CARBOHYDRATE PARAMETER FILE :  
This describes parameters in the CHARMM empirical energy function. The CHARMM 
parameter file contains the information necessary to calculate potential energy. Parameterization 
was carried out for few unusual sugars that are not available in the CHARMM force field such as 
KDO, Quip-N4-Malate & hexulosonic acid. Following IUPAC nomenclature, graphical 
representation of the repeating units are developed 
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  Figure 9 &10. Schematic representation of KDO pyranose 
forms and its derivatives. 
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Figure 11. Schematic representation of KDO furanose forms.
 
 
 
 
Figure 12. Schematic representation of mannose and its derivatives on left side and 
rhamnose derivative on the right side. 
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Figure 13. Schematic representation of galactose and its 
derivatives.
 
 
 
 
Figure 14. Schematic representation of glucose and its 
derivatives.  
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Figure 15. Schematic representation of Ribose and its 
derivatives. 
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2.2.3.2 Minimization of E. coli K antigen repeating unit 
Minimization enables the reduction of short contacts and refinement of structure with an output 
file having  no steric hindrance. Steepest descent (SD) is a gentle minimizer of molecules.  
Initially the PDB files should be given as an input for the CHARMM to get the structure read.  
Steepest descent : SD is one of the energy minimization method employed to locate potential 
energy of atoms. The distorted geometries of the atoms can be repaired by few cycles of the 
steepest descent method (1500 steps were used). It quickly removes bad contacts and improves 
theconformation. 
(http://www.uoxray.uoregon.edu/local/manuals/biosym/discovery/General/Minimization/Min_Al
go.html) 
ABNR / Newton-Raphson method : 1500 steps of minimization was carriedout after SD. 
(http://www.charmmtutorial.org/index.php/Minimization). 
Approximate Quadratic energy function is given by Taylor series as : 
       
P= Current point 
x= Arbitory point on the energy surface 
b= Gradient at P 
A= Hessian matrix at P 
2.2.3.3 Representation of data in the database 
Glycan representation 
Compared to proteins, glycan representation is found to be more complex due to 
branching. Following IUPAC nomenclature graphical representation of repeating unit was 
developed. The representation includes monosaccharide anomericity, linkages, 
substitutions, and modifications of sugar residues. 
      f(x)=f(P)-bx+1/2Ax2 
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Graphical Representations 
Though several graphical representations are available in different glyco-focused 
databases the present format uses the cartoon representation for the symbols of 
monosaccharide names. 
 (i) Pictorial representation 
According to IUPAC, for symbol representation of glycan structures, each sugar type should 
have the same symbol shape   (Varki et al., 2009). 
-Isomers  must be differentiated by colour change or shading. 
-Derivatives of sugars must be coloured with similar colours or with their shades 
-Representation of sugars with similar shapes  with different orientation should be avoided 
- Linkage information and conformation of sugar is represented in the form of text  
- The sugar symbols are attached to form the linear or branched glycan structure (Figure 16). 
 
 
Figure 16. Left side view, pictorial representation of Group-1 capsules K26, K27, 
K28 and right side view, 3D pymol view of K antigen structure. 
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   (ii) Naming scheme developed for EK3D 
A four letter code was developed for naming the sugar residues based on IUPAC 
nomenclature. The first letter represents the alpha or beta configuration of the sugar. 
Second position is assigned to the sugar name ( i.e, Glucose-G, Galactose-A, Mannose-
M, Fucose-F, Rhamnose-H, KDO- K, Fructose-C, etc). Third position represents the 
acetylation/ phosphorylation  of residues. Alphabets from A to H denote positions of O- 
acetylation from 1-8. Alphabets from I-P are assigned for N-acetylation positions from 1-
8. Phosphorylation positions 1-5 are given as  Q-U. X and Y alphabets represent mixture 
of O-acetylation, N-acetylation and phosphorylation. Combination of phosphorylation 
and acetylation are given numbers from 1-10 according to the existing glycan structures. 
Aminoacids like Serine and threonine are given  as SER and THR to satisfy the naming 
nomenclature of proteins. The fourth position in naming is given to the presence of 
pyranose /furanose form of sugar. 
A G B 0 
Α Glucose O-Acetylation at 2nd 
position 
By default pyranose 
 
Jmol representation 
The 3D structures of molecules can be viewed through Jmol. It is an interactive web 
browser applet for animated display of molecules. The PDB files of the antigen have to 
be placed in the specific directory for molecular visualization. The downloaded structure 
files can be viewed via Jmol application. 
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2.2.4 Multimer generation 
The polymeric structure of E. coli group capsules can be obtained by translational 
method. Twist and atoms involved in linkage are noted and deletion of water may be user 
defined. Multimeric repeat units of varying length can be given as input. 
 
Table 6. (A) Four letter code developed for naming residues for minimization of 
glycan structures  (B)  Sugar residues (one letter code) is shown position wise. 
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Table 7. List of unavailable residues developed for K antigen 
structures minimization. 
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Table 8. Overview of patches used in minimizing K antigen 
structures 
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List of  references for K antigen structures 
K1- 
https://books.google.co.in/books?id=s6gbXT15CeYC&pg=PA108&lpg=PA108&dq=Weintraub,
+A.+(2003)+Carbohydr.+Res.,+338,+2539+2547&source=bl&ots=ED1WD34Bjp&sig=ri8omlO
q8hJM2PhCKKz7nFAlkwY&hl=en&sa=X&ved=0CB0Q6AEwAGoVChMIjvvJ1PDZxgIVIiCm
Ch0CKAyF#v=onepage&q=E.coli&f=false  page 353 
K1, K2a, K5, K12/K82, K13, K27, K29, K30, K40, K92, K100- - (Whitfield, 2006) 
K2ab, K4, K7 & K56, K8, K11, K13, K14, K16, K18, K19, K20, K22, K51, K74, K93, - 
http://link.springer.com/chapter/10.1007/978-3-642-74694-9_2#page-1 
K3- (Dengler et al., 1988)  
K6-(Jennings et al., 1982)- Request 
K9-(Dutton et al., 1987) 
K10-(Sieberth et al., 1993) 
K12, K82, K23, K52, K57- (Ovodov, 2006) 
K15-(Jann and Jann, 1987)  
K24-(Lenter et al., 1990) 
K25-(Anderson et al., 1994)  
K26- (Beynon and Dutton, 1990) 
K28-(Altman and Dutton, 1985) 
K31-(Dutton et al., 1990) 
K32-(Annison et al., 1987) 
K33- (Leslie et al., 1998) 
K34-(Dutton and Kuma-Mintah, 1987) 
K35- (Hackland and Parolis, 1992) 
K36- (Parolis et al., 1988) 
K37-(Anderson et al., 1987) 
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K38- (Hackland et al., 1991) 
K39- (Parolis et al., 1989) 
K41- (Leslie et al., 1997) 
K42-(Niemann et al., 1978) 
K43-(Choy et al., 1995) 
K44-(Dutton et al., 1988) 
K46-(Dutton et al., 1992) 
K47-(de Bruin et al., 1992b) 
K48-(Whittaker et al., 1994a) 
K49- (Beynon et al., 1990) 
https://books.google.co.in/books?id=dd5xavr4bhmc&pg=pa215&dq=k1+structure+e.coli&hl=en
&sa=x&ei=jfgzvym6adedugtn8zqidg&ved=0ccyq6aewag#v=onepage&q=k21%20structure%20
e.coli&f=false page 216 
K50- (Grue et al., 1994b) 
K53—(Bax et al., 1988) 
K54-(Hofmann et al., 1985) 
K55-(Anderson and Parolis, 1989) 
K57-(Vann et al., 1981, Ovodov, 2006) 
K74-(Ahrens et al., 1988) 
K83-(Whittaker et al., 1994b) 
K84-(Whittaker et al., 1994c) 
K87-(Parolis et al., 1990) 
K93-(Bax et al., 1988) 
K95-(Orskov and Orskov, 1976) 
K96- (Jann et al., 1994) 
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K97-(Orskov and Orskov, 1976) 
K98-(Hahne et al., 1991) 
K101-(Grue et al., 1993) 
K102- (de Bruin et al., 1992a) 
K103- (Grue et al., 1994a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45 
 
REFERENCES 
AHRENS, R., JANN, B., JANN, K. & BRADE, H. 1988. Structure of the K74 antigen from Escherichia coli 
O44:K74:H18, a capsular polysaccharide containing furanosidic beta-KDO residues. Carbohydr 
Res, 179, 223-31. 
ALTMAN, E. & DUTTON, G. G. 1985. Chemical and structural analysis of the capsular polysaccharide from 
Escherichia coli O9:K28(A):H- (K28 antigen). Carbohydr Res, 138, 293-303. 
ANDERSON, A. N. & PAROLIS, H. 1989. Investigation of the structure of the capsular polysaccharide of 
Escherichia coli K55 using Klebsiella bacteriophage phi 5. Carbohydr Res, 188, 157-68. 
ANDERSON, A. N., PAROLIS, H. & PAROLIS, L. A. 1987. Structural investigation of the capsular 
polysaccharide from Escherichia coli O9:K37 (A 84a). Carbohydr Res, 163, 81-90. 
ANDERSON, A. N., PAROLIS, L. A. & PAROLIS, H. 1994. Structural determination of the capsular antigen of 
Escherichia coli O8:K25:H9. Carbohydr Res, 265, 41-7. 
ANNISON, G., DUTTON, G. G. & ALTMAN, E. 1987. Structure of the capsular polysaccharide of 
Escherichia coli O9:K32(A):H19. Carbohydr Res, 168, 89-102. 
BAX, A., SUMMERS, M. F., EGAN, W., GUIRGIS, N., SCHNEERSON, R., ROBBINS, J. B., ORSKOV, F., 
ORSKOV, I. & VANN, W. F. 1988. Structural studies of the Escherichia coli K93 and K53 capsular 
polysaccharides. Carbohydr Res, 173, 53-64. 
BEYNON, L. M. & DUTTON, G. G. 1990. The structure of Escherichia coli K26 antigen. Carbohydr Res, 200, 
457-68. 
BEYNON, L. M., DUTTON, G. G. & RICHARDS, J. C. 1990. Structure of the amino acid-containing capsular 
polysaccharide from Escherichia coli O8:K49:H21. Carbohydr Res, 205, 347-59. 
CHOY, Y. M., DUTTON, G. G., LESLIE, M. R., PAROLIS, H. & PAROLIS, L. A. 1995. The structure of the 
capsular polysaccharide of Escherichia coli O8:K43:H11. Carbohydr Res, 269, 295-302. 
DE BRUIN, A. H., PAROLIS, H. & PAROLIS, L. A. 1992a. The capsular antigen of Escherichia coli serotype 
O8:K102:H. Carbohydr Res, 235, 199-209. 
DE BRUIN, A. H., PAROLIS, H. & PAROLIS, L. A. 1992b. Structural elucidation of the capsular 
polysaccharide of E. coli serotype K47. Carbohydr Res, 233, 195-204. 
DENGLER, T., HIMMELSPACH, K., JANN, B. & JANN, K. 1988. Structure of the capsular K3 antigen of 
Escherichia coli 04:K3:H4, a polysaccharide containing a 4-deoxy-2-hexulosonic acid. Carbohydr 
Res, 178, 191-201. 
DUTTON, G. G., KARUNARATNE, D. N. & LIM, A. V. 1988. Escherichia coli serotype K44: an acidic capsular 
polysaccharide containing two 2-acetamido-2-deoxyhexoses. Carbohydr Res, 183, 111-22. 
DUTTON, G. G. & KUMA-MINTAH, A. 1987. Structure of Escherichia coli capsular antigen K34. Carbohydr 
Res, 169, 213-20. 
DUTTON, G. G., KUMA-MINTAH, A., NG, S. K., PAROLIS, H., DELL, A. & REASON, A. 1992. Determination 
of the structure of the capsular antigen of Escherichia coli O8:K46:H30, using FABMS and 2D-
NMR spectroscopy. Carbohydr Res, 231, 39-50. 
DUTTON, G. G., KUMA-MINTAH, A. & PAROLIS, H. 1990. The structure of Escherichia coli K31 antigen. 
Carbohydr Res, 197, 171-80. 
46 
 
DUTTON, G. G., PAROLIS, H. & PAROLIS, L. A. 1987. The structure of the neuraminic acid-containing 
capsular polysaccharide of Escherichia coli serotype K9. Carbohydr Res, 170, 193-206. 
GRUE, M. R., PAROLIS, H. & PAROLIS, L. A. 1993. Structural elucidation of the capsular polysaccharide of 
Escherichia coli serotype K101 by high resolution NMR spectroscopy. Carbohydr Res, 246, 283-
90. 
GRUE, M. R., PAROLIS, H. & PAROLIS, L. A. 1994a. Structural investigation of the capsular polysaccharide 
of Escherichia coli O101 : K103 : H- using bacteriophage degradation and NMR spectroscopy. 
Carbohydr Res, 262, 311-22. 
GRUE, M. R., PAROLIS, H. & PAROLIS, L. A. 1994b. Structure of the capsular antigen of Escherichia coli 
O8:K50:H. Carbohydr Res, 258, 233-41. 
HACKLAND, P. L. & PAROLIS, H. 1992. The structure of the capsular polysaccharide of Escherichia coli 
O9:K35:H. Carbohydr Res, 235, 211-20. 
HACKLAND, P. L., PAROLIS, H. & PAROLIS, L. A. 1991. Escherichia coli O9:K38 capsular antigen: another 
ribofuranose-containing glycan. Carbohydr Res, 219, 193-201. 
HAHNE, M., JANN, B. & JANN, K. 1991. Structure of the capsular polysaccharide (K98 antigen) of E. coli 
O7:K98:H6. Carbohydr Res, 222, 245-53. 
HATCHER, E., GUVENCH, O. & MACKERELL, A. D. 2009. CHARMM additive all-atom force field for 
aldopentofuranoses, methyl-aldopentofuranosides, and fructofuranose. J Phys Chem B, 113, 
12466-76. 
HOFMANN, P., JANN, B. & JANN, K. 1985. Structure of the amino acid-containing capsular 
polysaccharide (K54 antigen) from Escherichia coli O6:K54:H10. Carbohydr Res, 139, 261-71. 
JANN, B., KOCHANOWSKI, H. & JANN, K. 1994. Structure of the capsular K96 polysaccharide (K96 
antigen) from Escherichia coli O77:K96:H- and comparison with the capsular K54 polysaccharide 
(K54 antigen) from Escherichia coli O6:K54:H10. Carbohydr Res, 253, 323-7. 
JANN, K. & JANN, B. 1987. Polysaccharide antigens of Escherichia coli. Rev Infect Dis, 9 Suppl 5, S517-26. 
JENNINGS, H. J., ROSELL, K. G. & JOHNSON, K. G. 1982. Structure of the 3-deoxy-D-manno-octulosonic 
acid-containing polysaccharide (K6 antigen) from Escherichia coli LP 1092. Carbohydr Res, 105, 
45-56. 
LENTER, M. C., JANN, B. & JANN, K. 1990. Structure of the K24 antigen of E. coli O83:K24:H, a polymer 
that consists of alpha-Kdop and glycerol phosphate. Carbohydr Res, 208, 139-44. 
LESLIE, M. R., PAROLIS, H. & PAROLIS, L. A. 1997. Structural analysis of the capsular antigen of 
Escherichia coli O8:K41:H11. Carbohydr Res, 299, 197-202. 
LESLIE, M. R., PAROLIS, H., PAROLIS, L. A. & PETERSEN, B. O. 1998. The capsular antigen of Escherichia 
coli O9:K33:H-: a polysaccharide containing both pyruvate and O-acetyl groups. Carbohydr Res, 
309, 95-101. 
LOSS, A., BUNSMANN, P., BOHNE, A., LOSS, A., SCHWARZER, E., LANG, E. & VON DER LIETH, C. W. 2002. 
SWEET-DB: an attempt to create annotated data collections for carbohydrates. Nucleic Acids 
Res, 30, 405-8. 
MERRITT, J. H., OLLIS, A. A., FISHER, A. C. & DELISA, M. P. 2013. Glycans-by-design: engineering bacteria 
for the biosynthesis of complex glycans and glycoconjugates. Biotechnol Bioeng, 110, 1550-64. 
47 
 
NIEMANN, H., CHAKRABORTY, A. K., FRIEBOLIN, H. & STIRM, S. 1978. Primary structure of the 
Escherichia coli serotype K42 capsular polysaccharide and its serological identity with the 
Klebsiella K63 polysaccharide. J Bacteriol, 133, 390-1. 
ORSKOV, I. & ORSKOV, F. 1976. Five new Escherichia coli K antigens, K95, K96, K97, K98 and K100. Acta 
Pathol Microbiol Scand B, 84B, 321-5. 
ORSKOV, I., ORSKOV, F., JANN, B. & JANN, K. 1977. Serology, chemistry, and genetics of O and K antigens 
of Escherichia coli. Bacteriol Rev, 41, 667-710. 
OVODOV, Y. S. 2006. Bacterial capsular antigens. Structural patterns of capsular antigens. Biochemistry 
(Mosc), 71, 937-54. 
PAROLIS, H., PAROLIS, L. A. & STANLEY, S. M. 1988. The use of bacteriophage-mediated 
depolymerisation in the structural investigation of the capsular polysaccharide from Escherichia 
coli serotype K36. Carbohydr Res, 175, 77-83. 
PAROLIS, H., PAROLIS, L. A., STANLEY, S. M. & DUTTON, G. G. 1990. The structure of the capsular antigen 
from Escherichia coli O8:K87:H19. Carbohydr Res, 205, 361-70. 
PAROLIS, H., PAROLIS, L. A. & VENTER, R. D. 1989. Escherichia coli serotype-39 capsular polysaccharide: 
primary structure and depolymerisation by a bacteriophage-associated glycanase. Carbohydr 
Res, 185, 225-32. 
SIEBERTH, V., JANN, B. & JANN, K. 1993. Structure of the K10 capsular antigen from Escherichia coli 
O11:K10:H10, a polysaccharide containing 4,6-dideoxy-4-malonylamino-D-glucose. Carbohydr 
Res, 246, 219-28. 
VANN, W. F., SCHMIDT, M. A., JANN, B. & JANN, K. 1981. The structure of the capsular polysaccharide 
(K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-
heparin. Eur J Biochem, 116, 359-64. 
VARKI, A., CUMMINGS, R. D., ESKO, J. D., FREEZE, H. H., STANLEY, P., MARTH, J. D., BERTOZZI, C. R., 
HART, G. W. & ETZLER, M. E. 2009. Symbol nomenclature for glycan representation. Proteomics, 
9, 5398-9. 
WHITFIELD, C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev 
Biochem, 75, 39-68. 
WHITTAKER, D. V., PAROLIS, L. A. & PAROLIS, H. 1994a. Escherichia coli K48 capsular polysaccharide: a 
glycan containing a novel diacetamido sugar. Carbohydr Res, 256, 289-301. 
WHITTAKER, D. V., PAROLIS, L. A. & PAROLIS, H. 1994b. Structural elucidation of the capsular 
polysaccharide expressed by Escherichia coli O20:K83:H26 by high resolution NMR 
spectroscopy. Carbohydr Res, 253, 247-56. 
WHITTAKER, D. V., PAROLIS, L. A. & PAROLIS, H. 1994c. Structural elucidation of the capsular 
polysaccharide produced by Escherichia coli O20 : K84 : H26. Carbohydr Res, 262, 323-34. 
http://glycam.org/docs/articlesandciting/citing 
http://www.uoxray.uoregon.edu/local/manuals/biosym/discovery/General/Minimization/Min_Al
go.html  
48 
 
http://www.charmmtutorial.org/index.php/Minimization 
http://glycomics.scripps.edu/CFGnomenclature.pdf 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
49 
 
CHAPTER 3 
RESULTS 
We have developed EK3D as a comprehensive bank of E. coli K antigen structural data. 
Structures of 72 E. coli K antigens distributed across the 4 capsular groups have been provided. 
This is the first database with a specific focus on K antigen 3D structures. The main features of 
the database are described below. 
 
3.1 Implementation of EK3D as a database 
EK3D has emerged as a database management with necessary requirements serving as a 
bioinformatics tool providing the K antigen data of an important model organism like E. coli. 
The navigation bar offers different sections related to the E. coli K antigen study. Initially an 
introduction to capsular polysaccharide antigens is displayed in About K antigen section. The 
later section that is classification involves a brief discussion on the E. coli groups classification 
based on capsular biosynthesis and surface assembly. Links to different group biosynthesis 
mechanism, proteins involved are clearly depicted along with the pictorial representation. The 
group properties are listed in a table making it easy to understand. K antigen structures section 
offers structural representation of nearly more than 80 E. coli serotypes of different groups 
(Ovodov, 2006). The structures display type of sugars present, linkages & branching. To 
facilitate the interpretation of structure results, a file download page was developed. This will 
help users to download the required K antigen structure file and view the 3D model. Data on the 
available protein structural information like 2D, 3D and DSSP (secondary structural 
assignments) is provided in protein structures. The generation of polymeric CPS structures of 
varying lengths for modeling and molecular dynamic investigations has also been offered for 
users.  
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3.2 CREATING TOPOLOGY FILES FOR UNUSUAL SUGARS 
 
 
Figure 17. Newly developed KDO topology file. The atom numbers, 
atom types and their grouping pattern displaying the charges and 
bonds are clearly mentioned. 
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Figure 18. KDO acetylation and phosphorylation showing atom 
types and their charges. 
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Screen images of EK3D 
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Figure 24. EK3D sitemap showing related links on the top, navigation 
bar on the left & other features of the database at the bottom. 
3.2 Conclusion 
 Capsular polysaccharides are major virulence determinants of Gram-negative bacteria. They act 
as a physical barrier to host immune cell components and aid in immune evasion. The capsule 
has thus become an important antibacterial drug target. With the emergence of MDR bacterial 
strains, the need to develop new, efficient drugs has become even more significant. A large 
number of CPS structures have been discovered to date. For instance, in the well studied Gram-
negative bacterium, E. coli, there are about 80 K antigen structures. The high antigenic 
variability of the K antigen thus poses a major challenge. Though a large amount of information 
is available about the CPS from different organisms, it has not been efficiently organized. A 
centralized database of this information would be extremely valuable for researchers. The 
database EK3D that we have developed is an important step in this direction. It provides 
comprehensive structural information about the Group 1-4 K antigens of E. coli and about the 
proteins involved in its biosynthesis. Thus, the database developed would facilitate the designing 
of new drugs for therapeutic use and modeling studies. 
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